NASDAQ: BJDX - Bluejay Diagnostics, Inc.

六个月盈利: +456.92%
股息率: 0.00%
部门: Healthcare

促销时间表 Bluejay Diagnostics, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Bluejay Diagnostics, Inc.

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis.

更多详情
In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2021-11-10
ISIN US0956331039
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.bluejaydx.com
Цена ао 0.8116
每日价格变化: -3.47% (3.75)
每周价格变化: -5.73% (3.84)
每月价格变化: +4.02% (3.48)
3个月内价格变化: +2 483.87% (0.1401)
六个月内的价格变化: +456.92% (0.65)
每年价格变化: +196.72% (1.22)
3年内价格变化: +16.4% (3.11)
5年内价格变化: 0% (3.62)
10年价格变化: 0% (3.62)
年初以来价格变化: +5.23% (3.44)
所有参数

低估

姓名 意义 年级
P/S 647.73 1
P/BV 0.1231 10
P/E 0 0
EV/EBITDA 0.1555 10
全部的: 5.13

效率

姓名 意义 年级
ROA, % -204.45 0
ROE, % -343.85 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.0388 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 0 0
盈利能力 Ebitda, % 511.53 10
盈利能力 EPS, % 6002.75 10
全部的: 8
更多详情

机构 体积 分享, %
Sabby Management, LLC 149926 5.58
Armistice Capital, LLC 24230 0.9
Citadel Advisors Llc 22077 0.82
Tower Research Capital LLC (TRC) 3252 0.12
JP Morgan Chase & Company 61 0
Osaic Holdings Inc 25 0
Wells Fargo & Company 6 0



导师 职称 支付 出生年份
Mr. Indranil Dey Principal Financial, Accounting & Executive Officer, President, CEO and Director 413.16k 1963 (62 年)
Dr. Jason Cook Chief Technology Officer 278.42k 1982 (43 年)
Mr. Les DeLuca Vice President of Operations N/A
Mr. Kevin Vance Chief Commercial Officer N/A 1958 (67 年)
Mark W. Feinberg Chief Medical Advisor N/A
Dr. Mark W. Feinberg M.D. Chief Medical Advisor N/A

地址: United States, Acton. MA, 360 Massachusetts Avenue - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.bluejaydx.com